South-East Asia (WHO region) vs Togo: Confirmed cases of MDR-TB started treatment for MDR-TB
South-East Asia (WHO region)
83.0%
in 2012
Togo
100.0%
in 2012
South-East Asia (WHO region) rank
5th
Togo rank
3rd
Confirmed cases of MDR-TB started treatment for MDR-TB over time
- South-East Asia (WHO region)
- Togo
How they compare
Togo currently reports 100.0% against 83.0% in South-East Asia (WHO region), a difference of 17.0%.
That makes Togo's figure about 1.2 times South-East Asia (WHO region)'s.
The two have swapped places 2 times across 5 shared years of data; in 2008 it was Togo ahead.
South-East Asia (WHO region) ranks 5th and Togo ranks 3rd of 10 groups.
South-East Asia (WHO region) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South-East Asia (WHO region) | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 61.0% | 25.0% | 36.0% | South-East Asia (WHO region) |
| 2010s | 83.0% | 66.7% | 16.3% | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of mdr-tb started treatment for mdr-tb, South-East Asia (WHO region) or Togo?
- Togo, at 100.0% against 83.0% in South-East Asia (WHO region) as of 2012.
- What is the difference in confirmed cases of mdr-tb started treatment for mdr-tb between South-East Asia (WHO region) and Togo?
- 17.0%, with Togo ahead.
- How many years of comparable data are there for South-East Asia (WHO region) and Togo?
- 5 years are reported by both, from 2008 to 2012.
- How do South-East Asia (WHO region) and Togo rank globally for confirmed cases of mdr-tb started treatment for mdr-tb?
- South-East Asia (WHO region) ranks 5th and Togo ranks 3rd of 10 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of MDR-TB started treatment for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.